The WHO has given a green light to widespread use of GlaxoSmithKline's malaria vaccine in Africa, in what could be a major turning point in the fight against the disease. The RTS,S/AS01 vaccine ...

One example of this is GSK’s commitment to make its new malaria vaccine RTS,S affordable, the company planning to price it at £8.50 (10.42 US dollars) per child, based on demand of around 100 ...

After calling Rockville, Maryland, home for more than eight years, Big Pharma GSK is planning to move its vaccine and ...

Both of the malaria vaccines prequalified by the World Health Organisation (WHO) and recommended for use in children are pre-erythrocytic. These are GSK’s Mosquirix (recommended since 2021 ...

The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...

GlaxoSmithKline (GSK ... It’s not that the Gates Foundation is snubbing malaria vaccines — as one of Gavi’s biggest donors, Gates is helping to fund the R21 rollout. But rather than put ...

Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...

How do Sanofi CEO Paul Hudson and GSK CEO Emma Walmsley—who lead two of the top vaccine companies in the world—feel about the movement and how it could affect their businesses? Tuesday at the ...

GSK blames political and regulatory pressures for the decline in its vaccine’s business in 2024, as it expects sales to further shrink in 2025. Despite these challenges, GSK beat Q4 2024 ...

GSK adds that the strength of these will overcome short-term vaccine challenges from external pressures in the US and China. The Brentford, U.K.-based company remains confident that Arexvy ...

Expert Rev Vaccines. 2008;7(2):223-240. ME-TRAP Oxford University, MVI, Wellcome Trust Multiepitope string expressed in fowlpox and MVA Liver stage IIb CS + LSA1 epitope in attenuated viruses ...